Related Experiment Video
Updated: Aug 26, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Retinoblastoma: from bench to bedside
Richard L Hurwitz1, Patricia Chévez-Barrios, Milton Boniuk
1Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. rhurwitz@bcm.tmc.edu
Insights
Retinoblastoma (Rb), a childhood eye cancer caused by RB1 gene mutations, can be heritable or sporadic. While metastatic Rb lacks effective treatment, early-stage cases are curable, with research focusing on eye-saving strategies and animal models.
Area of Science:
- Pediatric Oncology
- Ophthalmology
- Cancer Genetics
Background:
- Retinoblastoma (Rb) is the most frequent primary ocular malignancy in children.
- It arises from mutations in the RB1 gene, with 40% of cases being heritable (constitutional) and 60% sporadic.
- Rb predominantly affects young children and can metastasize to extraocular sites.
Purpose of the Study:
- To summarize the current understanding of Retinoblastoma (Rb).
- To discuss the genetic basis, clinical presentation, and treatment landscape of Rb.
- To review the utility of animal models in Rb research.
Main Methods:
- Literature review of Retinoblastoma (Rb) pathogenesis, clinical features, and therapeutic approaches.
- Analysis of genetic factors, including constitutional and sporadic RB1 mutations.
- Evaluation of xenograft and transgenic animal models for studying Rb.
Main Results:
- Rb is primarily caused by RB1 gene mutations, leading to heritable or sporadic forms.
- Non-metastatic Rb is curable via enucleation, with emerging focus on eye salvage.
- Existing animal models offer distinct advantages and limitations for Rb research.
Conclusions:
- Understanding Rb's genetic underpinnings is crucial for diagnosis and treatment.
- Advancements in treatment aim to preserve the affected eye.
- Animal models are essential tools for dissecting Rb mechanisms and testing novel therapies.
Abstract:
Retinoblastoma (Rb) is the most common primary ocular malignancy of children and is caused by a mutation in the gene RB1. Approximately 40% of cases are associated with one or more constitutional mutations, and are therefore heritable, whereas the other 60% are sporadic. Rb is exclusively found in young children. In some cases, Rb tumours metastasise to extraocular organs including bone, lung and brain. Although there is no effective treatment for metastatic disease, non-metastatic cases can be cured by removal of the eye(enucleation). Newer treatment strategies emphasise salvaging the affected eye whenever possible. Animal models of Rb have been developed with xenograft and transgenic techniques. Each model has both strengths and weaknesses for exploring the mechanisms of disease development and progression and the efficacy of new treatment strategies.
